Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jankovic

Neurology

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Neurology|April 1, 1983
Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsyJ Jankovic
Neurology|March 1, 1985
Long-term study of pergolide in Parkinson's diseaseJ Jankovic
Neurology|February 24, 2001
Complications and limitations of drug therapy for Parkinson's diseaseJ Jankovic
Neurology|June 15, 2000
Essential tremor: clinical characteristicsJ Jankovic
Neurology|December 1, 1996
Restless legs syndrome: clinicoetiologic correlatesW Ondo, J Jankovic
Neurology|June 1, 1986
Hyperkinetic mutism: bilateral ballism and basal ganglia calcificationS Inbody, J Jankovic
Neurology|April 1, 1987
Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled studyJ Jankovic, J Orman
Neurology|April 1, 1988
Focal task-specific tremor and dystonia: categorization of occupational movement disordersF Rosenbaum, J Jankovic
Neurology|February 1, 1990
Botulinum toxin injections for cervical dystoniaJ Jankovic, K Schwartz
Neurology|September 1, 1995
Response and immunoresistance to botulinum toxin injectionsJ Jankovic, K Schwartz
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Neurology|April 1, 1983
Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsyJ Jankovic
Neurology|March 1, 1985
Long-term study of pergolide in Parkinson's diseaseJ Jankovic
Neurology|February 24, 2001
Complications and limitations of drug therapy for Parkinson's diseaseJ Jankovic
Neurology|June 15, 2000
Essential tremor: clinical characteristicsJ Jankovic
Neurology|December 1, 1996
Restless legs syndrome: clinicoetiologic correlatesW Ondo, J Jankovic
Neurology|June 1, 1986
Hyperkinetic mutism: bilateral ballism and basal ganglia calcificationS Inbody, J Jankovic
Neurology|April 1, 1987
Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled studyJ Jankovic, J Orman
Neurology|April 1, 1988
Focal task-specific tremor and dystonia: categorization of occupational movement disordersF Rosenbaum, J Jankovic
Neurology|February 1, 1990
Botulinum toxin injections for cervical dystoniaJ Jankovic, K Schwartz
Neurology|September 1, 1995
Response and immunoresistance to botulinum toxin injectionsJ Jankovic, K Schwartz
Pageof 9